H. Van Randenborgh

458 total citations
20 papers, 346 citations indexed

About

H. Van Randenborgh is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, H. Van Randenborgh has authored 20 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Rheumatology and 5 papers in Surgery. Recurrent topics in H. Van Randenborgh's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (7 papers) and Urologic and reproductive health conditions (5 papers). H. Van Randenborgh is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (7 papers) and Urologic and reproductive health conditions (5 papers). H. Van Randenborgh collaborates with scholars based in Germany, Italy and United States. H. Van Randenborgh's co-authors include R. Härtung, Roger Paul, Hubert Kübler, Jürgen Breul, R. Paul, Uwe Treiber, Raymonde Busch, Markus Schwaiger, Michael Souvatzoglou and Gregor Weirich and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Urology.

In The Last Decade

H. Van Randenborgh

20 papers receiving 342 citations

Peers

H. Van Randenborgh

PRM

SURGE

RHEUM

UROLO

ONCOL

Tatsuro Murase Japan

S. Holmäng Sweden

Jane Nguyen United States

Soloway Ms United States

Akinori Minato Japan

G. Zampa Italy

Ahmed Elshafei United States

Ross Snow Australia

Esther Hanspeter Italy

Marlies Marx Germany

Tatsuro Murase Japan

H. Van Randenborgh

81 ×0.4

PRM

206 ×1.7

SURGE

61 ×0.7

RHEUM

75 ×0.9

UROLO

61 ×1.2

ONCOL

Citations per year, relative to H. Van Randenborgh H. Van Randenborgh (= 1×) peers Tatsuro Murase

Countries citing papers authored by H. Van Randenborgh

Since Specialization

Citations

This map shows the geographic impact of H. Van Randenborgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Van Randenborgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Van Randenborgh more than expected).

Fields of papers citing papers by H. Van Randenborgh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Van Randenborgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Van Randenborgh. The network helps show where H. Van Randenborgh may publish in the future.

Co-authorship network of co-authors of H. Van Randenborgh

This figure shows the co-authorship network connecting the top 25 collaborators of H. Van Randenborgh. A scholar is included among the top collaborators of H. Van Randenborgh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Van Randenborgh. H. Van Randenborgh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brill, T., Hubert Kübler, Heike Pohla, et al.. (2009). Therapeutic Vaccination with an Interleukin-2–Interferon-γ-Secreting Allogeneic Tumor Vaccine in Patients with Progressive Castration-Resistant Prostate Cancer: A Phase I/II Trial. Human Gene Therapy. 20(12). 1641–1651. 20 indexed citations

Gänsbacher, Bernd, T. Brill, Bernd Eisele, et al.. (2007). Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer—A phase I/II trial. Journal of Clinical Oncology. 25(18_suppl). 5127–5127. 1 indexed citations

Paul, Roger, et al.. (2006). Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology. 67(1). 137–141. 27 indexed citations

Picchio, Maria, Uwe Treiber, Ambros J. Beer, et al.. (2006). Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.. PubMed. 47(6). 938–44. 91 indexed citations

Paul, R., et al.. (2005). Peniskarzinom — Nachsorge mit Konsequenz. Der Urologe. 44(9). 1031–1036. 3 indexed citations

Paul, R., Carolin Knebel, H. Van Randenborgh, et al.. (2005). Inzidentelles Prostatakarzinom: Kann und soll die radikale Prostatektomie danach empfohlen werden?. Der Urologe. 44(9). 1052–1058. 10 indexed citations

Paul, Roger, et al.. (2005). Optimization of Prostatic Biopsy: A Prospective Randomized Trial Comparing the Sextant Biopsy with a 10-Core Biopsy. Urologia Internationalis. 74(3). 203–208. 11 indexed citations

Treiber, Uwe, Hubert Kübler, H. Van Randenborgh, et al.. (2005). 633Diagnostic efficacy of 11C-choline positron emission tomography in patients scheduled for cystectomy. European Urology Supplements. 4(3). 161–161. 4 indexed citations

Paul, Roger, et al.. (2004). Residual Benign Prostatic Glands at the Urethrovesical Anastomosis after Radical Retropubic Prostatectomy: Prediction and Impact on Disease Outcome. European Urology. 46(3). 321–326. 19 indexed citations

10.

Kübler, Hubert, H. Van Randenborgh, Uwe Treiber, et al.. (2004). In vitro cytotoxic effects of imatinib in combination with anticancer drugs in human prostate cancer cell lines. The Prostate. 63(4). 385–394. 34 indexed citations

11.

Paul, R., et al.. (2004). Der Einfluss verschiedener Drainagesysteme bei der radikalen retropubischen Prostatektomie - eine prospektiv randomisierte Studie. Aktuelle Urologie. 35(5). 413–417. 1 indexed citations

12.

Paul, Roger, et al.. (2004). Morbidity of Prostatic Biopsy for Different Biopsy Strategies: Is There a Relation to Core Number and Sampling Region?. European Urology. 45(4). 450–456. 32 indexed citations

13.

Kübler, Hubert, H. Van Randenborgh, Uwe Treiber, et al.. (2004). Combined application of imatinib and standard chemotherapeutics results in additive cytotoxic effects in human prostate cancer cell lines. Journal of Clinical Oncology. 22(14_suppl). 4737–4737. 1 indexed citations

14.

Randenborgh, H. Van, R. Paul, Hubert Kübler, Jürgen Breul, & R. Härtung. (2004). Improved urinary continence after radical retropubic prostatectomy with preparation of a long, partially intraprostatic portion of the membraneous urethra: an analysis of 1013 consecutive cases. Prostate Cancer and Prostatic Diseases. 7(3). 253–257. 48 indexed citations

15.

Höfer, Christian, H. Van Randenborgh, A. Lehmer, R. Härtung, & Jürgen Breul. (2003). Transcutaneous IL-2 uptake mediated by Transfersomes® depends on concentration and fractionated application. Cytokine. 25(4). 141–146. 11 indexed citations

16.

Paul, R., Hubert Kübler, H. Van Randenborgh, & R. Härtung. (2002). Prognostic significance of the TNM-Staging-System of 1987 and 1997 as compared to the Robson-classification for renal cell cancer of 1969. mediaTUM (Technical University of Munich). 1 indexed citations

17.

Zantl, Niko, Ambros J. Beer, H. Van Randenborgh, & R. Härtung. (2002). Die virtuelle Endoskopie des Harntrakts. Der Urologe. 41(6). 552–558. 2 indexed citations

18.

Randenborgh, H. Van, et al.. (2002). Extramammary Paget’s Disease of Penis and Scrotum. The Journal of Urology. 168(6). 2540–2541. 26 indexed citations

19.

Randenborgh, H. Van, et al.. (2002). Improved urinary continence in radical retropubic prostatectomy after preparation of a long intraprostatic ureteral stump - results of a questionnaire in 575 consecutive cases. European Urology Supplements. 1(1). 71–71. 3 indexed citations

20.

Randenborgh, H. Van, et al.. (2001). Neoadjuvante Hormontherapie des lokalisierten Prostatakarzinoms vor kurativer radikaler Prostatektomie - Vorteil oder Nachteil?. Aktuelle Urologie. 32(4). 165–172. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact